Brief: Healius Posts HY Underlying EBITDA Of A$159.1 Million
Feb 27 (Reuters) - Healius Ltd HLS.AX :
* HY UNDERLYING EBITDA OF A$159.1 MILLION
* HY TOTAL REVENUE A$849 MILLION VERSUS A$864.1 MILLION
* HY UNDERLYING NET LOSS AFTER TAX A$14.2 MILLION VERSUS
PROFIT
A$8.1 MILLION
* EXPECTS UNDERLYING FY 2024 EBITDA OF A$359 MILLION - A$369
MILLION
* SEES FY 2024 UNDERLYING EBIT OF A$70 MILLION - A$80
MILLION
Source text for Eikon: ID:nASX4jVHM5
Further company coverage: HLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028